2009, ISBN 9781416052722, xv, 280
Book
2013, ISBN 1421408015, xiii, 319
Book
European Heart Journal, ISSN 0195-668X, 2015, Volume 36, Issue 41, pp. 2793 - 2867l
Myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | STRUCTURAL HEART-DISEASE | Cardiomyopathy | Congenital heart disease | Cardiac resynchronization therapy | Guidelines | EXPERT CONSENSUS STATEMENT | ACUTE MYOCARDIAL-INFARCTION | QUALITY-OF-LIFE | IMPLANTABLE-CARDIOVERTER-DEFIBRILLATOR | Resuscitation | Heart failure | Stable coronary artery disease | Implantable cardioverter defibrillator | Ventricular arrhythmia | Sudden cardiac death | Valvular heart disease | Tachycardia | BUNDLE-BRANCH BLOCK | TERM-FOLLOW-UP | LONG-QT-SYNDROME | POSITIVE AIRWAY PRESSURE | Acute coronary syndrome | CORONARY-ARTERY-DISEASE | Defibrillator | Cardiac Resynchronization Therapy - methods | Sleep Apnea, Obstructive - therapy | Humans | Ventricular Dysfunction, Left - complications | Death, Sudden, Cardiac - prevention & control | Mental Disorders - complications | Sleep Apnea, Obstructive - complications | Cardiotonic Agents - therapeutic use | Myocardial Infarction - therapy | Out-of-Hospital Cardiac Arrest - therapy | Sports - physiology | Ventricular Dysfunction, Left - therapy | Defibrillators | Heart Valve Diseases - complications | Female | Drug Therapy, Combination | Child | Arrhythmias, Cardiac - genetics | Terminal Care - methods | Pregnancy Complications, Cardiovascular - therapy | Acute Disease | Arrhythmias, Cardiac - therapy | Risk Assessment | Myocarditis - complications | Stroke Volume - physiology | Emergency Treatment - methods | Anti-Arrhythmia Agents - therapeutic use | Autopsy - methods | Nervous System Diseases - complications | Cardiomyopathies - therapy | Nervous System Diseases - therapy | Catheter Ablation - methods | Pregnancy | Myocardial Infarction - complications | Myocarditis - therapy | Coronary Artery Disease - therapy | Heart Defects, Congenital - complications | Heart Transplantation - methods | Coronary Artery Disease - complications | Primary Prevention - methods | Quality of Life | Cardiomyopathies - complications | Heart Valve Diseases - therapy | Aged | Heart Defects, Congenital - therapy | Early Diagnosis
Journal Article
Nature, ISSN 0028-0836, 2012, Volume 487, Issue 7407, pp. 325 - 329
During progression of atherosclerosis, myeloid cells destabilize lipid-rich plaques in the arterial wall and cause their rupture, thus triggering myocardial...
PROGENITOR CELLS | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | HEMATOPOIETIC STEM-CELLS | BONE-MARROW | MONOCYTE SUBSETS | NICHE | ACUTE CORONARY SYNDROMES | PLAQUES | IDENTIFICATION | ARTERY-DISEASE | Atherosclerosis - pathology | Monocytes - cytology | Mice, Inbred C57BL | Spleen - cytology | Stem Cells - cytology | Atherosclerosis - etiology | Inflammation - complications | Myocardial Infarction - complications | Animals | Apolipoproteins E - genetics | Hematopoietic Stem Cells - cytology | Myocardial Infarction - pathology | Mice | Complications and side effects | Prognosis | Atherosclerosis | Development and progression | Research | Risk factors | Heart attack | Proteins | Studies | Spleen | Hypotheses | Stroke | Rodents | Stem cells | Bone marrow | Tomography | Cell adhesion & migration
PROGENITOR CELLS | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | HEMATOPOIETIC STEM-CELLS | BONE-MARROW | MONOCYTE SUBSETS | NICHE | ACUTE CORONARY SYNDROMES | PLAQUES | IDENTIFICATION | ARTERY-DISEASE | Atherosclerosis - pathology | Monocytes - cytology | Mice, Inbred C57BL | Spleen - cytology | Stem Cells - cytology | Atherosclerosis - etiology | Inflammation - complications | Myocardial Infarction - complications | Animals | Apolipoproteins E - genetics | Hematopoietic Stem Cells - cytology | Myocardial Infarction - pathology | Mice | Complications and side effects | Prognosis | Atherosclerosis | Development and progression | Research | Risk factors | Heart attack | Proteins | Studies | Spleen | Hypotheses | Stroke | Rodents | Stem cells | Bone marrow | Tomography | Cell adhesion & migration
Journal Article
1993, ISBN 1879702673, 246
Book
Circulation, ISSN 0009-7322, 04/2009, Volume 119, Issue 14, pp. 1873 - 1882
Background-Treatments for non-ST-segment-elevation myocardial infarction (NSTEMI) reduce ischemic events but increase bleeding. Baseline prediction of bleeding...
Myocardial infarction | Risk assessment | Bleeding | ENOXAPARIN | risk assessment | CARDIAC & CARDIOVASCULAR SYSTEMS | bleeding | myocardial infarction | ACUTE CORONARY SYNDROMES | BIVALIRUDIN | IMPACT | ANGIOPLASTY | CLOPIDOGREL | TOLERABILITY | PERIPHERAL VASCULAR DISEASE | INTERVENTION | CREATININE CLEARANCE | CLINICAL-OUTCOMES | Blood Pressure | Creatinine | Heart Rate | Predictive Value of Tests | Myocardial Infarction - mortality | Hemorrhage - epidemiology | Risk Assessment | Humans | Middle Aged | Risk Factors | Hematocrit | Acute Coronary Syndrome - mortality | Acute Coronary Syndrome - physiopathology | Male | Myocardial Infarction - complications | Diabetic Angiopathies - physiopathology | Acute Coronary Syndrome - complications | Algorithms | Angina, Unstable - complications | Hemorrhage - classification | Female | Myocardial Infarction - physiopathology | Aged | Care and treatment | Physiological aspects | Diagnosis | Heart conduction system | Hemorrhage | Risk factors | Heart attack | non-ST-segment elevation myocardial infarction
Myocardial infarction | Risk assessment | Bleeding | ENOXAPARIN | risk assessment | CARDIAC & CARDIOVASCULAR SYSTEMS | bleeding | myocardial infarction | ACUTE CORONARY SYNDROMES | BIVALIRUDIN | IMPACT | ANGIOPLASTY | CLOPIDOGREL | TOLERABILITY | PERIPHERAL VASCULAR DISEASE | INTERVENTION | CREATININE CLEARANCE | CLINICAL-OUTCOMES | Blood Pressure | Creatinine | Heart Rate | Predictive Value of Tests | Myocardial Infarction - mortality | Hemorrhage - epidemiology | Risk Assessment | Humans | Middle Aged | Risk Factors | Hematocrit | Acute Coronary Syndrome - mortality | Acute Coronary Syndrome - physiopathology | Male | Myocardial Infarction - complications | Diabetic Angiopathies - physiopathology | Acute Coronary Syndrome - complications | Algorithms | Angina, Unstable - complications | Hemorrhage - classification | Female | Myocardial Infarction - physiopathology | Aged | Care and treatment | Physiological aspects | Diagnosis | Heart conduction system | Hemorrhage | Risk factors | Heart attack | non-ST-segment elevation myocardial infarction
Journal Article
JAMA, ISSN 0098-7484, 11/2014, Volume 312, Issue 19, pp. 2019 - 2027
IMPORTANCE: Little information exists about the anatomical characteristics and clinical relevance of non–infarct-related artery (IRA) disease among patients...
Myocardial Infarction - mortality | Prevalence | Humans | Middle Aged | Male | Risk | Incidence | Myocardial Infarction - complications | Registries - statistics & numerical data | Coronary Artery Disease - complications | Female | Aged | Coronary Artery Disease - epidemiology | Retrospective Studies | Korea - epidemiology | Percutaneous Coronary Intervention | Complications and side effects | Usage | Coronary heart disease | Risk factors | Heart attack | Prevalence studies (Epidemiology) | Studies | Clinical trials | Heart attacks | Coronary vessels | Mortality
Myocardial Infarction - mortality | Prevalence | Humans | Middle Aged | Male | Risk | Incidence | Myocardial Infarction - complications | Registries - statistics & numerical data | Coronary Artery Disease - complications | Female | Aged | Coronary Artery Disease - epidemiology | Retrospective Studies | Korea - epidemiology | Percutaneous Coronary Intervention | Complications and side effects | Usage | Coronary heart disease | Risk factors | Heart attack | Prevalence studies (Epidemiology) | Studies | Clinical trials | Heart attacks | Coronary vessels | Mortality
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9905, pp. 1638 - 1645
Summary Background In current international guidelines the recommendation for intra-aortic balloon pump (IABP) use has been downgraded in cardiogenic shock...
Internal Medicine | MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | EARLY REVASCULARIZATION | MANAGEMENT | TASK-FORCE | ESC | PREDICTORS | GUIDELINES | ASSOCIATION | TRENDS | Myocardial Infarction - mortality | Follow-Up Studies | Shock, Cardiogenic - complications | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Intra-Aortic Balloon Pumping - mortality | Myocardial Revascularization | Myocardial Infarction - complications | Myocardial Infarction - therapy | Time Factors | Quality of Life | Female | Surveys and Questionnaires | Aged | Care and treatment | Intra-aortic balloon counterpulsation | Patient outcomes | Heart attack | Cardiovascular disease | Heart attacks | Drug therapy | Mortality | Coronary vessels | Quality of life
Internal Medicine | MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | EARLY REVASCULARIZATION | MANAGEMENT | TASK-FORCE | ESC | PREDICTORS | GUIDELINES | ASSOCIATION | TRENDS | Myocardial Infarction - mortality | Follow-Up Studies | Shock, Cardiogenic - complications | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Intra-Aortic Balloon Pumping - mortality | Myocardial Revascularization | Myocardial Infarction - complications | Myocardial Infarction - therapy | Time Factors | Quality of Life | Female | Surveys and Questionnaires | Aged | Care and treatment | Intra-aortic balloon counterpulsation | Patient outcomes | Heart attack | Cardiovascular disease | Heart attacks | Drug therapy | Mortality | Coronary vessels | Quality of life
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 12/2012, Volume 308, Issue 22, pp. 2380 - 2389
Context While the delivery of cell therapy after ST-segment elevation myocardial infarction (STEMI) has been evaluated in previous clinical trials, the...
PROGENITOR CELLS | INTRACORONARY INFUSION | MEDICINE, GENERAL & INTERNAL | STEM-CELLS | THERAPY | EFFICACY | REGENERATION | IMPAIRS | DOUBLE-BLIND | LATETIME | REDUCED NEOVASCULARIZATION CAPACITY | Double-Blind Method | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Treatment Outcome | Bone Marrow Transplantation - methods | Magnetic Resonance Imaging | Myocardial Infarction - complications | Myocardial Infarction - therapy | Ventricular Dysfunction, Left - therapy | Time Factors | Female | Aged | Bone marrow | Medical research | Heart attacks | Medical treatment
PROGENITOR CELLS | INTRACORONARY INFUSION | MEDICINE, GENERAL & INTERNAL | STEM-CELLS | THERAPY | EFFICACY | REGENERATION | IMPAIRS | DOUBLE-BLIND | LATETIME | REDUCED NEOVASCULARIZATION CAPACITY | Double-Blind Method | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Treatment Outcome | Bone Marrow Transplantation - methods | Magnetic Resonance Imaging | Myocardial Infarction - complications | Myocardial Infarction - therapy | Ventricular Dysfunction, Left - therapy | Time Factors | Female | Aged | Bone marrow | Medical research | Heart attacks | Medical treatment
Journal Article
European Heart Journal, ISSN 0195-668X, 2012, Volume 33, Issue 20, pp. 2569 - 2619
Acute coronary syndromes Ischaemic heart disease | Reperfusion therapy | Primary percutaneous coronary intervention Antithrombotic therapy | Secondary prevention | Acute myocardial infarction | ST-segment elevation | Guidelines | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL STENTS | Primary percutaneous coronary intervention | AMERICAN-HEART-ASSOCIATION | PERCUTANEOUS CORONARY INTERVENTION | INTRAAORTIC BALLOON COUNTERPULSATION | Antithrombotic therapy | LEFT-VENTRICULAR DYSFUNCTION | DUAL ANTIPLATELET THERAPY | SUSPECTED CARDIOGENIC-SHOCK | IN-HOSPITAL MORTALITY | Acute coronary syndromes | Ischaemic heart disease | CONVERTING-ENZYME INHIBITOR | DRUG-ELUTING STENTS | Antifibrinolytic Agents - therapeutic use | Humans | Heart Failure - physiopathology | Hyperglycemia - complications | Anxiety - prevention & control | Long-Term Care | Hemodynamics - physiology | Cardiomyopathies - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Myocardial Infarction - therapy | Out-of-Hospital Cardiac Arrest - therapy | Percutaneous Coronary Intervention - methods | Fibrinolytic Agents - therapeutic use | Electrocardiography | Cardiac Imaging Techniques - methods | Platelet Aggregation Inhibitors - therapeutic use | Dyspnea - prevention & control | Exercise Therapy - methods | Myocardial Infarction - diagnosis | Heart Failure - complications | Coronary Artery Bypass - methods | Arrhythmias, Cardiac - therapy | Pain - prevention & control | Risk Assessment | Risk Reduction Behavior | Time-to-Treatment | Emergency Treatment - methods | Biomedical Research - trends | Arrhythmias, Cardiac - etiology | Hospitalization | Out-of-Hospital Cardiac Arrest - diagnosis | Forecasting | Myocardial Reperfusion - methods | Cardiomyopathies - therapy | Myocardial Infarction - complications | Emergency Medical Services - organization & administration | General Practice - organization & administration | Hyperglycemia - therapy
Journal Article